Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia (Q24306456)

defense response to Gram-negative bacterium

GOA release 2020-03-11

1 reference

Plasminogen activator inhibitor 1

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

1 reference

Sandrine Florquin

0 references

Tom van der Poll

Tom van der Poll

0 references

Peter Carmeliet

Peter Carmeliet

0 references

Joris Jth Roelofs

1 reference

ORCID Public Data File 2021

Rosemarijn Renckens

Rosemarijn Renckens

0 references

Peter I Bonta

Peter I Bonta

0 references

Carlie J M de Vries

Carlie J M de Vries

0 references

Marcel Levi

Marcel Levi

0 references

Cornelis van't Veer

Cornelis van't Veer

0 references

author name string

Joris J T H Roelofs

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial

0 references

language of work or name

English

0 references

publication date

15 February 2007

0 references

published in

Blood

0 references

volume

109

0 references

issue

0 references

page(s)

1593-601

0 references

cites work

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Procoagulant and fibrinolytic activity in ventilator-associated pneumonia: impact of inadequate antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

TAFI and PAI-1 levels in human sepsis

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Beyond fibrinolysis: the role of plasminogen activator inhibitor-1 and vitronectin in vascular wound healing.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Innate immunity and pulmonary host defense

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Klebsiella bacteraemia: community versus nosocomial infection

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Plasminogen activator inhibitor type-1 deficiency attenuates murine antigen-induced arthritis

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Leptin and host defense against Gram-positive and Gram-negative pneumonia in mice

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

On the role of plasminogen activator inhibitor-1 in adipose tissue development and insulin resistance in mice

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Transient transgenic expression of gamma interferon promotes Legionella pneumophila clearance in immunocompetent hosts

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Intrapulmonary expression of macrophage inflammatory protein 1alpha (CCL3) induces neutrophil and NK cell accumulation and stimulates innate immunity in murine bacterial pneumonia

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Plasminogen activator inhibitor-1 potentiates LPS-induced neutrophil activation through a JNK-mediated pathway.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Adenovirus-mediated transfer of a gene encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Alveolar Fibrin Formation Caused by Enhanced Procoagulant and Depressed Fibrinolytic Capacities in Severe Pneumonia

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Disparate role of the beta 2-integrin CD18 in the local accumulation of neutrophils in pulmonary and cutaneous inflammation in the rabbit

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Time course of hemostatic abnormalities in sepsis and its relation to outcome.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Plasminogen activator inhibitor-1 supports IL-8-mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8/heparan sulfate/syndecan-1 complexes

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

Regulation of lipopolysaccharide-induced lung inflammation by plasminogen activator Inhibitor-1 through a JNK-mediated pathway

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2006-05-025197

7 January 2021

10.1182/BLOOD-2006-05-025197

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_pehuok2obzh5xb5knsanm7atv4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pehuok2obzh5xb5knsanm7atv4

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17032919

1 reference

Consolidated OpenCitations Corpus – April 2017